Genetic variance in Nitric Oxide Synthase and Endothelin Genes among children with and without Endothelial Dysfunction

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Chatsuriyawong, Siriporn ^a,b   Gozal, David ^a   Kheirandish Gozal, Leila ^a   Bhattacharjee, Rakesh ^a   Khalyfa, Ahamed A ^a   Wang, Yang ^a   Hakonarson, Hakon ^c   Keating, Brendan ^c   Sukhumsirichart, Wasana ^b   Khalyfa, Abdelnaby ^a  

^a UNIVERSITY OF CHICAGO   (United States)

^b SRINAKHARINWIROT UNIVERSITY   (Thailand)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Children; EDN; Endothelial; Endothelial dysfunction; NOS; SNP

Indexed keywords

C REACTIVE PROTEIN; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENDOTHELIN; ENDOTHELIN 1; ENDOTHELIN 2; ENDOTHELIN 3; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR; GENOMIC DNA; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; LIPID; NEURONAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE;

ARTICLE; CARDIOVASCULAR RISK; CHILD; COHORT ANALYSIS; COMPUTER PROGRAM; CONTROLLED STUDY; EDN1 GENE; ENDOTHELIAL DYSFUNCTION; ENDOTHELIN GENE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; MUTATION RATE; NITRIC OXIDE SYNTHASE GENE; NOS1 GENE; OBESITY; PRESCHOOL CHILD; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SCHOOL CHILD; SINGLE NUCLEOTIDE POLYMORPHISM;

ALLELES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DEMOGRAPHY; ENDOTHELINS; ENDOTHELIUM, VASCULAR; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; HAPLOTYPES; HUMANS; LINKAGE DISEQUILIBRIUM; MALE; NITRIC OXIDE SYNTHASE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; REPRODUCIBILITY OF RESULTS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION;

EID: 84884517687     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-227     Document Type: Article

References (66)

1. Kelishadi R. Childhood overweight, obesity, and the metabolic syndrome in developing countries. Epidemiol Rev 2007, 29:62-76. 10.1093/epirev/mxm003, 17478440.
2. Haslam DW, James WP. Obesity. Lancet 2005, 366(9492):1197-1209. 10.1016/S0140-6736(05)67483-1, 16198769.
3. Wang Y, Mi J, Shan XY, Wang QJ, Ge KY. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. International journal of obesity 2007, 31(1):177-188. 10.1038/sj.ijo.0803354, 16652128.
4. Reilly JJ, Kelly J. Long-term impact of overweight and obesity in childhood and adolescence on morbidity and premature mortality in adulthood: systematic review. International journal of obesity 2011, 35(7):891-898. 10.1038/ijo.2010.222, 20975725.
5. Ribeiro MM, Silva AG, Santos NS, Guazzelle I, Matos LN, Trombetta IC, Halpern A, Negrao CE, Villares SM. Diet and exercise training restore blood pressure and vasodilatory responses during physiological maneuvers in obese children. Circulation 2005, 111(15):1915-1923. 10.1161/01.CIR.0000161959.04675.5A, 15837944.
6. Aggoun Y, Farpour-Lambert NJ, Marchand LM, Golay E, Maggio AB, Beghetti M. Impaired endothelial and smooth muscle functions and arterial stiffness appear before puberty in obese children and are associated with elevated ambulatory blood pressure. Eur Heart J 2008, 29(6):792-799. 10.1093/eurheartj/ehm633, 18245115.
7. Bhattacharjee R, Alotaibi WH, Kheirandish-Gozal L, Capdevila OS, Gozal D. Endothelial dysfunction in obese non-hypertensive children without evidence of sleep disordered breathing. BMC pediatrics 2010, 10:8. 10.1186/1471-2431-10-8, 2829007, 20156343.
8. Gozal D, Kheirandish-Gozal L. Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more. Am J Respir Crit Care Med 2008, 177(4):369-375. 10.1164/rccm.200608-1190PP, 2258438, 17975198.
9. Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 2004, 109(23 Suppl 1):III27-III32.
10. Hirata Y, Nagata D, Suzuki E, Nishimatsu H, Suzuki J, Nagai R. Diagnosis and treatment of endothelial dysfunction in cardiovascular disease. International heart journal 2010, 51(1):1-6. 10.1536/ihj.51.1, 20145343.
11. Versari D, Daghini E, Virdis A, Ghiadoni L, Taddei S. Endothelial dysfunction as a target for prevention of cardiovascular disease. Diabetes Care 2009, 32(Suppl 2):S314-S321. 2811443, 19875572.
12. Hingorani AD. Polymorphisms in endothelial nitric oxide synthase and atherogenesis: John French Lecture 2000. Atherosclerosis 2001, 154(3):521-527. 10.1016/S0021-9150(00)00699-7, 11257252.
13. Kugiyama K, Yasue H, Okumura K, Ogawa H, Fujimoto K, Nakao K, Yoshimura M, Motoyama T, Inobe Y, Kawano H. Nitric oxide activity is deficient in spasm arteries of patients with coronary spastic angina. Circulation 1996, 94(3):266-271. 10.1161/01.CIR.94.3.266, 8759065.
14. Cooke JP, Dzau VJ. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997, 48:489-509. 10.1146/annurev.med.48.1.489, 9046979.
15. Lamas S, Marsden PA, Li GK, Tempst P, Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci USA 1992, 89(14):6348-6352. 10.1073/pnas.89.14.6348, 49498, 1378626.
16. Bogdan C. Nitric oxide and the immune response. Nature immunology 2001, 2(10):907-916. 10.1038/ni1001-907, 11577346.
17. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 2001, 357(Pt 3):593-615. 1221991, 11463332.
18. Hansel TT, Kharitonov SA, Donnelly LE, Erin EM, Currie MG, Moore WM, Manning PT, Recker DP, Barnes PJ. A selective inhibitor of inducible nitric oxide synthase inhibits exhaled breath nitric oxide in healthy volunteers and asthmatics. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2003, 17(10):1298-1300.
19. Cook S, Vollenweider P, Menard B, Egli M, Nicod P, Scherrer U. Increased eNO and pulmonary iNOS expression in eNOS null mice. The European respiratory journal : official journal of the European Society for Clinical Respiratory Physiology 2003, 21(5):770-773.
20. Vaughan DJ, Brogan TV, Kerr ME, Deem S, Luchtel DL, Swenson ER. Contributions of nitric oxide synthase isozymes to exhaled nitric oxide and hypoxic pulmonary vasoconstriction in rabbit lungs. American journal of physiology Lung cellular and molecular physiology 2003, 284(5):L834-L843.
21. Silkoff PE, McClean PA, Slutsky AS, Furlott HG, Hoffstein E, Wakita S, Chapman KR, Szalai JP, Zamel N. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med 1997, 155(1):260-267. 10.1164/ajrccm.155.1.9001322, 9001322.
22. Alvarez R, Gonzalez P, Batalla A, Reguero JR, Iglesias-Cubero G, Hevia S, Cortina A, Merino E, Gonzalez I, Alvarez V, et al. Association between the NOS3 (-786 T/C) and the ACE (I/D) DNA genotypes and early coronary artery disease. Nitric oxide : biology and chemistry/official journal of the Nitric Oxide Society 2001, 5(4):343-348.
23. Salazar LA, Hirata MH, Giannini SD, Forti N, Diament J, Lima TM, Hirata RD. Seven DNA polymorphisms at the candidate genes of atherosclerosis in Brazilian women with angiographically documented coronary artery disease. Clinica chimica acta; international journal of clinical chemistry 2000, 300(1-2):139-149.
24. Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS. Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int 2000, 57(2):405-413. 10.1046/j.1523-1755.2000.00860.x, 10652017.
25. Wang XL, Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease. Mol Genet Metab 2000, 70(4):241-251. 10.1006/mgme.2000.3033, 10993711.
26. Zintzaras E, Kitsios G, Stefanidis I. Endothelial NO synthase gene polymorphisms and hypertension: a meta-analysis. Hypertension 2006, 48(4):700-710. 10.1161/01.HYP.0000238124.91161.02, 16940230.
27. Brunner F, Bras-Silva C, Cerdeira AS, Leite-Moreira AF. Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacology & therapeutics 2006, 111(2):508-531. 10.1016/j.pharmthera.2005.11.001, 3775628, 24058883.
28. Colombo MG, Ciofini E, Paradossi U, Bevilacqua S, Biagini A. ET-1 Lys198Asn and ET(A) receptor H323H polymorphisms in heart failure. A case-control study. Cardiology 2006, 105(4):246-252. 10.1159/000092374, 16582543.
29. Herrmann S, Schmidt-Petersen K, Pfeifer J, Perrot A, Bit-Avragim N, Eichhorn C, Dietz R, Kreutz R, Paul M, Osterziel KJ. A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy. Eur Heart J 2001, 22(20):1948-1953. 10.1053/euhj.2001.2626, 11601839.
30. Telgmann R, Harb BA, Ozcelik C, Perrot A, Schonfelder J, Nonnenmacher A, Brand M, Schmidt-Petersen K, Dietz R, Kreutz R, et al. The G-231A polymorphism in the endothelin-A receptor gene is associated with lower aortic pressure in patients with dilated cardiomyopathy. American journal of hypertension 2007, 20(1):32-37. 10.1016/j.amjhyper.2006.06.016, 17198909.
31. Li H, Louey JW, Choy KW, Liu DT, Chan WM, Chan YM, Fung NS, Fan BJ, Baum L, Chan JC, et al. EDN1 Lys198Asn is associated with diabetic retinopathy in type 2 diabetes. Mol Vis 2008, 14:1698-1704. 2538496, 18806884.
32. Yasuda H, Kamide K, Takiuchi S, Matayoshi T, Hanada H, Kada A, Yang J, Miwa Y, Yoshii M, Horio T, et al. Association of single nucleotide polymorphisms in endothelin family genes with the progression of atherosclerosis in patients with essential hypertension. J Hum Hypertens 2007, 21(11):883-892. 10.1038/sj.jhh.1002234, 17525706.
33. National High Blood Pressure Education Program Working Group on High Blood Pressure in C, Adolescents The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004, 114(2 Suppl 4th Report):555-576. National High Blood Pressure Education Program Working Group on High Blood Pressure in C, Adolescents.
34. Bhattacharjee R, Kim J, Alotaibi WH, Kheirandish-Gozal L, Capdevila OS, Gozal D. Endothelial dysfunction in children without hypertension: potential contributions of obesity and obstructive sleep apnea. Chest 2012, 141(3):682-691. 10.1378/chest.11-1777, 3296460, 22030801.
35. Wahlberg E, Olofsson P, Swendenborg J, Fagrell B. Changes in postocclusive reactive hyperaemic values as measured with laser Doppler fluxmetry after infrainguinal arterial reconstructions. Eur J Vasc Endovasc Surg 1995, 9(2):197-203. 10.1016/S1078-5884(05)80090-5, 7627653.
36. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985, 28(7):412-419. 10.1007/BF00280883, 3899825.
37. Keating BJ, Tischfield S, Murray SS, Bhangale T, Price TS, Glessner JT, Galver L, Barrett JC, Grant SF, Farlow DN, et al. Concept, design and implementation of a cardiovascular gene-centric 50 k SNP array for large-scale genomic association studies. PLoS One 2008, 3(10):e3583. 10.1371/journal.pone.0003583, 2571995, 18974833.
38. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25(4):402-408. 10.1006/meth.2001.1262, 11846609.
39. Zintzaras E, Lau J. Synthesis of genetic association studies for pertinent gene-disease associations requires appropriate methodological and statistical approaches. JCE 2008, 61(7):634-645.
40. Zintzaras E, Lau J. Trends in meta-analysis of genetic association studies. J Hum Genet 2008, 53(1):1-9. 10.1007/s10038-007-0223-5, 18071627.
41. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, Higgins J, DeFelice M, Lochner A, Faggart M, et al. The structure of haplotype blocks in the human genome. Science 2002, 296(5576):2225-2229. 10.1126/science.1069424, 12029063.
42. Lewontin RC. On measures of gametic disequilibrium. Genetics 1988, 120(3):849-852. 1203562, 3224810.
43. Schaid DJ, Rowland CM, Tines DE, Jacobson RM, Poland GA. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet 2002, 70(2):425-434. 10.1086/338688, 384917, 11791212.
44. Sarwar N, Danesh J, Eiriksdottir G, Sigurdsson G, Wareham N, Bingham S, Boekholdt SM, Khaw KT, Gudnason V. Triglycerides and the risk of coronary heart disease: 10,158 incident cases among 262,525 participants in 29 Western prospective studies. Circulation 2007, 115(4):450-458. 10.1161/CIRCULATIONAHA.106.637793, 17190864.
45. Medow MS, Taneja I, Stewart JM. Cyclooxygenase and nitric oxide synthase dependence of cutaneous reactive hyperemia in humans. American journal of physiology Heart and circulatory physiology 2007, 293(1):H425-H432. 10.1152/ajpheart.01217.2006, 17369458.
46. Valle Jimenez M, Estepa RM, Camacho RM, Estrada RC, Luna FG, Guitarte FB. Endothelial dysfunction is related to insulin resistance and inflammatory biomarker levels in obese prepubertal children. European journal of endocrinology/European Federation of Endocrine Societies 2007, 156(4):497-502. 10.1530/EJE-06-0662, 17389466.
47. Talmud PJ, Cooper JA, Gaunt T, Holmes MV, Shah S, Palmen J, Drenos F, Shah T, Kumari M, Kivimaki M, et al. Variants of ADRA2A are associated with fasting glucose, blood pressure, body mass index and type 2 diabetes risk: meta-analysis of four prospective studies. Diabetologia 2011, 54(7):1710-1719. 10.1007/s00125-011-2108-6, 3110279, 21455730.
48. Fox ER, Young JH, Li Y, Dreisbach AW, Keating BJ, Musani SK, Liu K, Morrison AC, Ganesh S, Kutlar A, et al. Association of genetic variation with systolic and diastolic blood pressure among African Americans: the Candidate Gene Association Resource study. Hum Mol Genet 2011, 20(11):2273-2284. 10.1093/hmg/ddr092, 3090190, 21378095.
49. Ronald J, Rajagopalan R, Cerrato F, Nord AS, Hatsukami T, Kohler T, Marcovina S, Heagerty P, Jarvik GP. Genetic variation in LPAL2, LPA, and PLG predicts plasma lipoprotein(a) level and carotid artery disease risk. Stroke; a journal of cerebral circulation 2011, 42(1):2-9. 10.1161/STROKEAHA.110.591230, 3766605, 24058906.
50. Saleheen D, Alexander M, Rasheed A, Wormser D, Soranzo N, Hammond N, Butterworth A, Zaidi M, Haycock P, Bumpstead S, et al. Association of the 9p21.3 locus with risk of first-ever myocardial infarction in Pakistanis: case-control study in South Asia and updated meta-analysis of Europeans. Arterioscler Thromb Vasc Biol 2010, 30(7):1467-1473. 10.1161/ATVBAHA.109.197210, 20395598.
51. Van Gaal LF, Mertens IL, De Block CE. Mechanisms linking obesity with cardiovascular disease. Nature 2006, 444(7121):875-880. 10.1038/nature05487, 17167476.
52. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of overweight to cardiovascular risk factors among children and adolescents: the Bogalusa Heart Study. Pediatrics 1999, 103(6 Pt 1):1175-1182.
53. Morrison JA, Laskarzewski PM, Rauh JL, Brookman R, Mellies M, Frazer M, Khoury P, deGroot I, Kelly K, Glueck CJ. Lipids, lipoproteins, and sexual maturation during adolescence: the Princeton maturation study. Metabolism 1979, 28(6):641-649. 10.1016/0026-0495(79)90017-9, 449703.
54. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996, 128(5 Pt 1):608-615.
55. Sinha R, Fisch G, Teague B, Tamborlane WV, Banyas B, Allen K, Savoye M, Rieger V, Taksali S, Barbetta G, et al. Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002, 346(11):802-810. 10.1056/NEJMoa012578, 11893791.
56. Tounian A, Aggoun Y, Lacorte JM, Dubern B, Clement K, Bonnet D, Tounian P. Influence of polymorphisms in candidate genes on early vascular alterations in obese children. Archives of cardiovascular diseases 2010, 103(1):10-18. 10.1016/j.acvd.2009.10.001, 20142115.
57. Lillie EO, Mahata M, Khandrika S, Rao F, Bundey RA, Wen G, Chen Y, Taupenot L, Smith DW, Mahata SK, et al. Heredity of endothelin secretion: human twin studies reveal the influence of polymorphism at the chromogranin A locus, a novel determinant of endothelial function. Circulation 2007, 115(17):2282-2291. 10.1161/CIRCULATIONAHA.106.648345, 17438153.
58. Gormley K, Bevan S, Hassan A, Markus HS. Polymorphisms in genes of the endothelin system and cerebral small-vessel disease. Stroke; a journal of cerebral circulation 2005, 36(8):1656-1660. 10.1161/01.STR.0000173173.38289.69, 3766605, 24058906.
59. Dell'Omo G, Penno G, Pucci L, Fotino C, Lucchesi D, Del Prato S, Pedrinelli R. Lack of association between endothelial nitric oxide synthase gene polymorphisms, microalbuminuria and endothelial dysfunction in hypertensive men. J Hypertens 2007, 25(7):1389-1395. 10.1097/HJH.0b013e3281268548, 17563560.
60. Song XY, Lee SY, Ma RC, So WY, Cai JH, Tam C, Lam V, Ying W, Ng MC, Chan JC. Phenotype-genotype interactions on renal function in type 2 diabetes: an analysis using structural equation modelling. Diabetologia 2009, 52(8):1543-1553. 10.1007/s00125-009-1400-1, 19479237.
61. Tiret L, Poirier O, Hallet V, McDonagh TA, Morrison C, McMurray JJ, Dargie HJ, Arveiler D, Ruidavets JB, Luc G, et al. The Lys198Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people. Hypertension 1999, 33(5):1169-1174. 10.1161/01.HYP.33.5.1169, 10334806.
62. Asai T, Ohkubo T, Katsuya T, Higaki J, Fu Y, Fukuda M, Hozawa A, Matsubara M, Kitaoka H, Tsuji I, et al. Endothelin-1 gene variant associates with blood pressure in obese Japanese subjects: the Ohasama Study. Hypertension 2001, 38(6):1321-1324. 10.1161/hy1101.095333, 11751711.
63. Jin JJ, Nakura J, Wu Z, Yamamoto M, Abe M, Tabara Y, Yamamoto Y, Igase M, Kohara K, Miki T. Association of endothelin-1 gene variant with hypertension. Hypertension 2003, 41(1):163-167. 10.1161/01.HYP.0000043680.75107.CF, 12511547.
64. Barath A, Endreffy E, Bereczki C, Gellen B, Szucs B, Nemeth I, Turi S. Endothelin-1 gene and endothelial nitric oxide synthase gene polymorphisms in adolescents with juvenile and obesity-associated hypertension. Acta Physiologica 2007, 94(1-2):49-66.
65. Pare G, Serre D, Brisson D, Anand SS, Montpetit A, Tremblay G, Engert JC, Hudson TJ, Gaudet D. Genetic analysis of 103 candidate genes for coronary artery disease and associated phenotypes in a founder population reveals a new association between endothelin-1 and high-density lipoprotein cholesterol. Am J Hum Genet 2007, 80(4):673-682. 10.1086/513286, 1852704, 17357073.
66. Panoulas VF, Douglas KM, Smith JP, Taffe P, Stavropoulos-Kalinoglou A, Toms TE, Elisaf MS, Nightingale P, Kitas GD. Polymorphisms of the endothelin-1 gene associate with hypertension in patients with rheumatoid arthritis. Endothelium : journal of endothelial cell research 2008, 15(4):203-212.